Concurrent irradiation with the anti-programmed cell death ligand-1 immune checkpoint blocker durvalumab: Single centre subset analysis from a phase 1/2 trial (Q39266352)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Concurrent irradiation with the anti-programmed cell death ligand-1 immune checkpoint blocker durvalumab: Single centre subset analysis from a phase 1/2 trial |
scientific article |
Statements
1 reference
Concurrent irradiation with the anti-programmed cell death ligand-1 immune checkpoint blocker durvalumab: Single centre subset analysis from a phase 1/2 trial (English)
1 reference
Antonin Levy
1 reference
Christophe Massard
1 reference
Eric Deutsch
1 reference
17 October 2016
1 reference
1 reference
68
1 reference
156-162
1 reference
Identifiers
1 reference
1 reference